Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/1999
11/30/1999US5994136 Method and means for producing high titer, safe, recombinant lentivirus vectors
11/30/1999US5994134 Preparing a culture of producer cells coated microcarriers, seeding the bioreactors at high density, increasing infectivity of the producer cells to the virus, culturing the cells under perfusion conditions in serum containing media
11/30/1999US5994132 Adenovirus vectors
11/30/1999US5994128 Primary cells containing a nucleic acid molecule from the adenovirus early genes, eia and eib; an encapsidating signal sequence and an inverted terminal repeat with no overlapping sequences with the target cells; autoimmune disease therapy
11/30/1999US5994115 Artificial system for the production of infectious human papillomavirus
11/30/1999US5994083 Collect serum samples from infected pateints with antibodies and a healthy individual, identify antibodies which bind antigens specific to the disease from phage library; select phages that display antigen recognized by antibody; vaccines
11/30/1999US5993824 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
11/30/1999US5993821 Antigens and vaccines containing said vlps that may be effective in treatment of infections caused by such viruses.
11/25/1999WO1999060148A2 Display of viral proteins as ligands for cell-surface receptor
11/25/1999WO1999060147A2 Targeted delivery through a cationic amino acid transporter
11/25/1999WO1999060145A1 Mutant herpes simplex viruses and uses thereof
11/25/1999WO1999060144A1 Methods and compositions for producing viral particles
11/25/1999WO1999060143A1 Amphotropic retrovirus packaging cell line, process for its production and use thereof
11/25/1999WO1999060131A2 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
11/25/1999WO1999060110A2 Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy
11/25/1999WO1999059645A1 Methods and apparatus for inactivating contaminants in biological fluid
11/25/1999WO1999059613A1 BINDING MOIETIES FOR UROKINASE PLASMINOGEN ACTIVATOR (uPA)
11/25/1999WO1999005527A3 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
11/25/1999CA2332639A1 Methods and compositions for producing viral particles
11/25/1999CA2329270A1 Targeted delivery through a cationic amino acid transporter
11/25/1999CA2329139A1 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
11/25/1999CA2328597A1 Display of viral proteins as ligands for cell-surface receptor
11/25/1999CA2328594A1 Mutant herpes simplex viruses and uses thereof
11/24/1999EP0959136A1 Targeted delivery through a cationic amino acid transporter
11/24/1999EP0959135A1 Display of viral proteins and targeted delivery to cellular receptor
11/24/1999EP0958371A2 Cytopathic viruses for therapy and prophylaxis of neoplasia
11/24/1999EP0958364A1 Immunotherapy and improved vaccines
11/24/1999CN1236390A Angiogenic factor and use thereof of treating cardiovascular disease
11/24/1999CN1235847A Method for preparing epidemic hemorrhagic fever vaccine
11/23/1999US5990388 Transgenic plant expressing a cloned dna encoding a vaccinia virus e3l protein at a level to complex and sequester double-stranded rna-like structure of virus/viroid; biological pest control; viricides
11/23/1999US5990383 Plant transformed with nucleotide sequence which encodes a vegetative insecticidal protein from bacillus species
11/23/1999US5989886 Method for the inhibition and prevention of viral replication using fusions of a virus protein and a destructive enzyme
11/23/1999US5989805 Immortal avian cell line to grow avian and animal viruses to produce vaccines
11/23/1999US5989563 Viral agent associated with mystery swine disease
11/23/1999US5989562 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
11/23/1999US5989561 Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
11/23/1999CA2033169C Improved biological insect control agents and methods of use
11/22/1999CA2238660A1 Gene sequences of rubella virus associated with attenuation
11/18/1999WO1999058726A1 Replication defective hiv vaccine
11/18/1999WO1999058705A1 Recombinant baculovirus-based insecticides
11/18/1999WO1999058655A2 Phage display selection system for folded proteins
11/18/1999WO1999050419A3 A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
11/18/1999WO1999050285A3 Production methods and uses of a retrovirus
11/18/1999WO1999041416A3 Compositions comprising viruses and methods for concentrating virus preparations
11/18/1999CA2331853A1 Recombinant baculovirus-based insecticides
11/18/1999CA2328422A1 Selection system
11/17/1999EP0957167A1 Production of heterodimeric human fertility hormones
11/17/1999EP0957162A1 Biological viral material obtained from a multiple sclerosis-associated virus strain infected cell line
11/17/1999EP0956355A2 Method for immortalizing cells
11/17/1999EP0956349A1 Synthetic hpv16 virus-like particles
11/17/1999EP0956343A1 Recombinant swinepox virus
11/17/1999EP0956045A2 Assembly-deficient herpesvirus vaccine
11/17/1999EP0955803A1 Plant retroviral polynucleotides and methods for use thereof
11/17/1999EP0604566B1 Chimeric and/or growth-restricted flaviviruses
11/16/1999US5985654 Gene which expresses a protein corresponding to the conserved exposed region of the m6 protein, a virulence factor of streptococcus; poxvirus such as vaccinia containing m6 gene used as vaccines against streptococcal infection
11/16/1999US5985642 Culturing primary chicken embryonic fibroblasts, passaging until senescence, concentrating to maintain confluence, isolating non-senescent cells, culturing for greater than 30 passages, introducing recombinant virus, isolating virus
11/16/1999US5985641 Non-infectious, replication-impaired, immunogenic human immunodeficiency virus type 1 retrovirus-like particles with multiple genetic deficiencies
11/16/1999US5985610 Gene expression in host cell of conformational epitopes
11/16/1999US5985546 Forming culture product; cytopathic effect
11/16/1999CA2088600C Herpes simplex virus vp16 vaccines
11/11/1999WO1999057304A1 Bacteriophage assay
11/11/1999WO1999057297A1 Viral production process
11/11/1999WO1999057295A1 Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
11/11/1999WO1999057290A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/11/1999WO1999057284A2 Attenuated influenza viruses
11/11/1999WO1999056774A1 Viral chimeras comprised of caev and hiv-1 genetic elements
11/11/1999DE19822115A1 Retrovirale Gentransfervektoren Retroviral gene transfer vectors
11/11/1999CA2330814A1 Bacteriophage assay
11/11/1999CA2328087A1 Partially deleted adenoviral vectors
11/11/1999CA2327584A1 Attenuated influenza viruses
11/10/1999EP0955374A2 Retroviral vectors for gene transfer
11/10/1999EP0955373A2 Packaging systems for human recombinant adenovirus to be used in gene therapy
11/10/1999EP0954593A1 Recombinant pox virus for immunization against tumor-associated antigens
11/10/1999EP0954592A1 System for the production of aav vectors
11/10/1999EP0954591A2 Mini-adenoviral vector
11/10/1999EP0954566A1 Nonoxynol-containing lipid vesicles with anti-viral and spermacidal activity
11/10/1999CN1234836A Retroviral vectors
11/10/1999CN1234835A Gene therapy for congestive heart failure
11/10/1999CN1234832A Phage having nuclear location signal
11/10/1999CN1234441A Recombined pure herpes virus built by using adhesive particles as basis and use thereof
11/09/1999US5981487 Method of inhibiting smooth muscle cell proliferation
11/09/1999US5981274 Genetically engineered viral genome with heterologous gene sequences which express functional gene product; for the encapsultion/packaging of virus genome; for antitumor agents, viricides and gene therapy for liver disorders
11/09/1999US5981163 Irradiating extracorporeal biological compositions such as blood and blood products in presence of quencher compound(s); deactivates viruses without substantial disruption or deactivation of cells and labile proteins
11/09/1999US5980906 Live recombinant avian vaccine using an avian herpesvirus as vector
11/09/1999US5980901 Viral defective interfering particles and uses thereof
11/04/1999WO1999055917A1 Mixed cell diagnostic systems
11/04/1999WO1999055893A1 Retroviral vectors including modified envelope escort proteins
11/04/1999WO1999055892A1 Use of triplex structure dna sequences for transferring nucleotide sequences
11/04/1999WO1999055366A1 Chimeras of hepatitis c virus and bovine viral diarrhea virus
11/04/1999WO1999055345A1 Combination viral-based and gene-based therapy of tumors
11/04/1999WO1999055132A2 Generation of packaging system for human recombinant adenoviral vectors
11/04/1999WO1999047648A3 Medium and method for viral propagation and growth
11/04/1999WO1999045104A3 Purification of virus preparations
11/04/1999WO1999036545A3 Adenoviral vectors with modified capsid proteins
11/04/1999CA2330086A1 Chimeras of hepatitis c virus and bovine viral diarrhea virus
11/04/1999CA2327506A1 Combination viral-based and gene-based therapy of tumors
11/04/1999CA2295105A1 Generation of packaging system for human recombinant adenoviral vectors
11/03/1999EP0953648A2 Viral defective vaccine produced by transcomplementing cell line
11/03/1999EP0953647A1 Method for preparing retrovirus vector for gene therapy
11/03/1999EP0953633A1 Cell culturing method and medium for producing proliferated, normal, differentiated human liver cells
1 ... 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 ... 267